Asymchem Laboratories (Tianjin) Co., Ltd. Share Price

Stocks

002821

CNE100002BZ6

Pharmaceuticals

OTC Markets Traded
End-of-day quote 19/08/2026 5-day change 1st Jan Change
170.59 CNY -3.76% Intraday chart for Asymchem Laboratories (Tianjin) Co., Ltd. -2.88% +83.57%

Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 59.62B 8.86B 7.6B 7.09B 6.51B 12.24B 847B 12.44B 83.71B 32.78B 425B 33.26B 32.53B 1,404B P/E 2026 *
43.8x
P/E 2027 * 34.8x
Enterprise Value 54.57B 8.11B 6.95B 6.49B 5.96B 11.2B 775B 11.39B 76.62B 30B 389B 30.44B 29.78B 1,285B EV / Sales 2026 *
6.75x
EV / Sales 2027 * 5.68x
Free-Float
61.14%
Yield 2026 *
0.86%
Yield 2027 * 1.05%
07-31 Asymchem Laboratories to Subscribe for Subsidiary's New Shares for 1.05 Billion Yuan; Shares Up 6% MT
07-29 Shanghai Asymchem Biotechnology Development Co., Ltd. announced that it expects to receive CNY 1.239699995 billion in funding from Asymchem Laboratories Co., Ltd., Suzhou Gao Ling Qirui Healthcare Investment, L.P. and another investor CI
07-27 AsymBio, Subsidiary of Asymchem Group Kicks Off Construction of Fengxian R&D Building CI
07-10 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy MT
07-10 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$131.48 From HK$115.43, Keeps at Buy MT
06-11 Asymchem Laboratories Co., Ltd. Approves Final Profit Distribution Plan to Be Implemented (A Shares) for 2025, Payable on June 26, 2026 CI
05-27 Asymbio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates CI
05-20 Citigroup's long position in H shares of Asymchem Laboratories (Tianjin) decreases to 4.99% on May 14 from 5.66%, HKEX filing says RE
05-15 Asymchem Laboratories Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2025, Payable on 24 July 2026 CI
05-13 Citigroup's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 5.36% on May 7, HKEX says RE
05-04 JPMorgan Chase's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 7.64% on Apr 28 from 8.18%, HKEX filing shows RE
04-28 Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8% MT
04-27 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
1 day-3.76%
1 week-2.88%
Current month+11.75%
1 month+5.31%
3 months+43.63%
6 months+69.61%
Current year+83.57%
1 week 167.3
Extreme 167.3
180.58
1 month 142.43
Extreme 142.43
188
Current year 91.33
Extreme 91.33
200
1 year 88.46
Extreme 88.46
200
3 years 59.55
Extreme 59.55
200
5 years 59.55
Extreme 59.55
380.35
10 years 13.09
Extreme 13.085713
380.35
Manager TitleAgeSince
Chief Executive Officer 70 06/10/1998
Chief Executive Officer 49 18/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 17/07/2011
Chairman 70 06/10/1998
Director/Board Member 65 17/07/2011
Date Insider Type Main position Quantity % Market Cap.
14/07/26
Tianjin Guorong Business Information Consulting Co. Ltd.
OtherCompany -315,000 1.1317%
08/07/26 Other

Chief Executive Officer

25,000 0.0898%
08/07/26
Tianjin Guorong Business Information Consulting Co. Ltd.
OtherCompany 25,000 0.0898%
Change 5-day change 1-year change 3-year change Capi.($)
-3.76%-2.88%+58.23%+38.13% 9.18B
+3.94%+4.70%+81.69%+132.28% 1,093B
+0.91%+4.83%+53.80%+63.41% 653B
+2.55%+7.02%+29.12%+77.29% 458B
+1.80%-0.41%+43.52%+44.05% 355B
+1.24%+1.00%+26.84%+42.21% 294B
+2.07%+1.74%+2.66%+13.06% 248B
+4.04%+6.23%+49.59%+69.59% 230B
+1.05%-2.52%-13.83%-52.13% 203B
+2.07%+8.67%+25.15%+94.43% 178B
Average +1.56%+1.22%+35.68%+52.23% 371.96B
Weighted average by Cap. +2.41%+1.66%+47.13%+73.97%

Financials

2026 *2027 *
Net sales 8.08B 1.2B 1.03B 962M 882M 1.66B 115B 1.69B 11.35B 4.44B 57.55B 4.51B 4.41B 190B 9.72B 1.44B 1.24B 1.16B 1.06B 2B 138B 2.03B 13.65B 5.34B 69.23B 5.42B 5.3B 229B
Net income 1.4B 208M 179M 167M 153M 288M 19.91B 293M 1.97B 771M 9.98B 782M 765M 33.01B 1.77B 263M 225M 211M 193M 363M 25.12B 369M 2.48B 973M 12.6B 987M 965M 41.66B
Net Debt -5.05B -750M -643M -601M -551M -1.04B -71.69B -1.05B -7.09B -2.78B -35.96B -2.82B -2.76B -119B -4.39B -652M -560M -523M -479M -902M -62.36B -917M -6.17B -2.41B -31.28B -2.45B -2.4B -103B
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Date Price Change Volume
18/08/26 CN¥170.59 -3.76% 11,994,030
18/08/26 CN¥177.25 +0.07% 10,432,929
17/08/26 CN¥177.12 +3.46% 12,059,671
14/08/26 CN¥171.20 -1.50% 11,747,748
13/08/26 CN¥173.81 -0.68% 17,410,824
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
170.59CNY
Average target price
160.45CNY
Spread / Average Target
-5.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002821 Stock